340 related articles for article (PubMed ID: 16686848)
1. Cytokine accumulation in photochemically treated and gamma-irradiated platelet concentrates during storage.
Apelseth TO; Hervig TA; Wentzel-Larsen T; Bruserud O
Transfusion; 2006 May; 46(5):800-10. PubMed ID: 16686848
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage.
Apelseth TØ; Bruserud Ø; Wentzel-Larsen T; Bakken AM; Bjørsvik S; Hervig T
Transfusion; 2007 Apr; 47(4):653-65. PubMed ID: 17381624
[TBL] [Abstract][Full Text] [Related]
3. Leukoreduced buffy coat-derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7 days: assessment of hemostatic function under flow conditions.
Lozano M; Galan A; Mazzara R; Corash L; Escolar G
Transfusion; 2007 Apr; 47(4):666-71. PubMed ID: 17381625
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light.
Wagner SJ; Skripchenko A; Myrup A; Awatefe H; Thompson-Montgomery D; Moroff G; Carmichael P; Lin L
Transfusion; 2009 Apr; 49(4):704-10. PubMed ID: 19171001
[TBL] [Abstract][Full Text] [Related]
5. Release of immune modulation factors from platelet concentrates during storage after photochemical pathogen inactivation treatment.
Cognasse F; Osselaer JC; Payrat JM; Chavarin P; Corash L; Garraud O
Transfusion; 2008 May; 48(5):809-13. PubMed ID: 18298593
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system.
Vetlesen A; Mirlashari MR; Ezligini F; Kjeldsen-Kragh J
Transfusion; 2007 Jan; 47(1):126-32. PubMed ID: 17207241
[TBL] [Abstract][Full Text] [Related]
7. Prevention of cytokine accumulation in platelets obtained with the COBE spectra apheresis system.
Palmer DS; Aye MT; Dumont L; Dumont D; McCombie N; Giulivi A; Rutherford B; Trudel E; Hashemi-Tavoularis S
Vox Sang; 1998; 75(2):115-23. PubMed ID: 9784664
[TBL] [Abstract][Full Text] [Related]
8. Platelet derived cytokine accumulation in platelet concentrates treated for pathogen reduction.
Tauszig ME; Picker SM; Gathof BS
Transfus Apher Sci; 2012 Feb; 46(1):33-7. PubMed ID: 22119364
[TBL] [Abstract][Full Text] [Related]
9. Generation of IL-8 and TNF-alpha in platelet concentrates during storage.
Shaiegan M; Pourfatollah AA; Namiri M; Babaee G
Arch Iran Med; 2006 Jan; 9(1):61-4. PubMed ID: 16649381
[TBL] [Abstract][Full Text] [Related]
10. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.
Janetzko K; Lin L; Eichler H; Mayaudon V; Flament J; Klüter H
Vox Sang; 2004 May; 86(4):239-45. PubMed ID: 15144528
[TBL] [Abstract][Full Text] [Related]
11. Release of potential immunomodulatory factors during platelet storage.
Cognasse F; Boussoulade F; Chavarin P; Acquart S; Fabrigli P; Lamy B; Garraud O
Transfusion; 2006 Jul; 46(7):1184-9. PubMed ID: 16836566
[TBL] [Abstract][Full Text] [Related]
12. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
[TBL] [Abstract][Full Text] [Related]
13. Effect of cold-storage in the accumulation of bioreactive substances in platelet concentrates treated with second messenger effects.
Ferrer F; Rivera J; Lozano ML; Corral J; García VV
Haematologica; 2001 May; 86(5):530-6. PubMed ID: 11410418
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of supernatant from pooled buffy-coat platelet concentrates throughout 7-day storage.
Glenister KM; Payne KA; Sparrow RL
Transfusion; 2008 Jan; 48(1):99-107. PubMed ID: 17894789
[TBL] [Abstract][Full Text] [Related]
15. Level of platelet-derived cytokines in leukoreduced red blood cells is influenced by the processing method and type of leukoreduction filter.
Glenister KM; Sparrow RL
Transfusion; 2010 Jan; 50(1):185-9. PubMed ID: 19694993
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 1 beta and tumor necrosis factor levels in stored platelet concentrates and the association with gene polymorphisms.
Addas-Carvalho M; Origa AF; Saad ST
Transfusion; 2004 Jul; 44(7):996-1003. PubMed ID: 15225239
[TBL] [Abstract][Full Text] [Related]
17. Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment.
Lin L; Conlan MG; Tessman J; Cimino G; Porter S
Transfusion; 2005 Oct; 45(10):1610-20. PubMed ID: 16181212
[TBL] [Abstract][Full Text] [Related]
18. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.
Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG
Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840
[TBL] [Abstract][Full Text] [Related]
19. [Determination of the cytokine level during storage of partially leukocyte-depleted (<0.5 x 10(9)) or totally leukocyte-depleted (<0.5 x 10(6)) platelets].
Algora M; Barbolla L; Zamora C; Moreno C; Rodríguez MA; Merino JL; Torres P
Sangre (Barc); 1997 Jun; 42(3):159-64. PubMed ID: 9381255
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
Moog R; Fröhlich A; Mayaudon V; Lin L
J Clin Apher; 2004; 19(4):185-91. PubMed ID: 15597347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
